在家用Palivizumab管理计划对有医疗复杂性的儿童的影响
Hina Emanuel1, Aravind Yadav1, Julie C Eapan1
1Department of Pediatrics, Division of Pulmonary Medicine, McGovern Medical School, University of Texas Health Science Center, Houston, TX 77030, USA.
在家用帕利维祖马布 (PH) 管理显著减少了医疗复杂性 (CMC) 的儿童的医疗保健遭遇. 这种以家庭为基础的方法降低了弱势儿科患者的医院访问和潜在感染.
科学领域:
- 儿科肺病学 儿科肺病学
- 传染性疾病 传染性疾病
- 医疗保健管理的管理
背景情况:
- 在家中使用帕利维祖马布 (Palivizumab,PH) 有望减少RSV感染.
- 通过限制暴露于与医疗相关的感染 (HAI),PH可能有利于患有医疗复杂性 (CMC) 的儿童.
研究的目的:
- 为了评估与临床治疗CMC相比,在家中服用帕利维祖马布的有效性.
- 评估对医疗保健利用的影响,包括面对面接触和住院治疗.
主要方法:
- 对41名患有CMC的儿童 (<2年) 进行前性研究,随机分配到PH或临床 (PC) 管理.
- 通过家庭通风分层;主要结果:总面对面接触;次要结果:非计划的访问和住院治疗.
- 进行了标准的频率学和贝叶斯分析.
主要成果:
- 与PC组 (n=28) 相比,PH组 (n=13) 的面对面接触总数 (4.5比8.8) 和住院病例 (0.3比1.25) 显著减少.
- 贝叶斯分析表明,有93%的受益概率有利于减少与PH的接触.
- 人口因素和阶层在不同群体之间很好地匹配.
结论:
- 在家中服用帕利维祖马布似乎减少了医疗复杂性的儿童的医疗保健利用率.
- 减少医疗机构暴露的家庭干预措施是CMC有前途的战略.
更多相关视频
08:04Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
09:01An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
相关概念视频
Asthma-IV: Nursing Management
First, in...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Cystic Fibrosis: Management
Sinus disease and chronic...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
